Background illustration for clinical trials search

Paid Clinical Trials Alberta

Discover 833 paid clinical trials in Alberta . Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

Implementing REmote SymPtom mOnitoring and maNagement (RESPONd)

for
Cancer
Location: Edmonton, Red Deer, Calgary
Sponsor: University of Calgary

Sex: All

Age: 18+

Code: NCT07024329

Recruiting

A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)

for
Gastrointestinal Neoplasms
Location: Calgary, Sherbrooke, New York NY, Toronto, Montreal,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT06885034

Phase1, Phase2, Recruiting

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

for
Malignant Glioma
Location: Halifax, Bangor ME, Scarborough ME, Boston MA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 1 - 21

Code: NCT05099003

Phase1, Phase2, Recruiting

A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity

for
Multiple Sclerosis Spasticity
Location: Foxborough MA, Levis, Montreal, Philadelphia PA, Ottawa,
Sponsor: Celgene

Sex: All

Age: 18 - 70

Code: NCT06782490

Phase2, Recruiting

OverTTuRe: Characteristics, Treatment Patterns and Outcomes of Patients With ATTR Amyloidosis

for
ATTR Amyloidosis
Location: Calgary
Sponsor: AstraZeneca

Sex: All

Age: 0+

Code: NCT06355934

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of Momelotinib in Participants With Low-risk Myelodysplastic Syndrome

for
Myelodysplastic Syndromes
Location: New Haven CT, Calgary, Toronto, Canton OH, Houston TX,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT06847867

Phase2, Recruiting

Prevention of Nephrotoxin-Induced Acute Kidney Injury Using Cilastatin

for
Acute Kidney Injury
Location: Edmonton, Calgary
Sponsor: Matthew James

Sex: All

Age: 18+

Code: NCT06886464

Phase2, Recruiting

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

for
B Acute Lymphoblastic Leukemia
Location: Scarborough ME, Boston MA, Providence RI, Worcester MA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 1 - 46

Code: NCT06124157

Phase2, Recruiting

Effect of NSAIDs on Union, Opioid Utilization and Pain Management for Tibia Fractures: A Pragmatic, Randomized Controlled Trial

for
Tibial Fractures, Pain
Location: Cambridge MA, Baltimore MD, Falls Church VA,
Sponsor: Major Extremity Trauma Research Consortium

Sex: All

Age: 18 - 70+

Code: NCT07006675

Phase3, Recruiting

The Effect of Targeting the Plantaris Muscle-tendon in Surgical Correction of Ankle Equinus in Children

for
Idiopathic Toe Walking, Cerebral Palsy,
Location: Edmonton
Sponsor: University of Alberta

Sex: All

Age: 4 - 17

Code: NCT07090057

Recruiting

A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis

for
Recurrent Langerhans Cell Histiocytosis,
Location: Halifax, Hartford CT, New Haven CT, Quebec, Sherbrooke,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0 - 22

Code: NCT05828069

Phase2, Recruiting

Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.

for
Relapsing Multiple Sclerosis
Location: Foxborough MA, Burlington MA, Levis, Teaneck NJ,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 40 - 70

Code: NCT06846281

Phase3, Recruiting

Adapting Rehabilitation Delivery for Maximum Impact at Home-2 (ReDI-2)

for
Knee Osteoarthritis, Hip Osteoarthritis
Location: Edmonton
Sponsor: University of Alberta

Sex: All

Age: 0+

Code: NCT07055113

Recruiting

Personalized Anti-Inflammatory Fibres in Ulcerative Colitis

for
Ulcerative Colitis
Location: Edmonton
Sponsor: University of Alberta

Sex: All

Age: 14+

Code: NCT06515210

Recruiting

Nimodipine Variability in SAH

for
Subarachnoid Aneurysm Hemorrhage,
Location: Richmond VA, Toronto, Edmonton
Sponsor: University of Alberta

Sex: All

Age: 18 - 70+

Code: NCT07065903

Recruiting

MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)

for
Transthyretin Amyloidosis (ATTR) With Cardiomyopathy
Location: Boston MA, New Haven CT, New York NY, Montreal,
Sponsor: Intellia Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT06128629

Phase3, Recruiting

Dialectal Behaviour Therapy to Enhance Health Behaviour Change for Adolescents Living With Obesity (DIRECTION Trial)

for
Prevention, Type2Diabetes
Location: Hamilton, Winnipeg, Calgary
Sponsor: University of Manitoba

Sex: All

Age: 14 - 17

Code: NCT05338944

Recruiting

Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations

for
Non-small Cell Lung Cancer
Location: Boston MA, New York NY, Fairfax VA, Orange City FL,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT07195695

Phase3, Recruiting

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

for
Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic,
Location: Quebec, White Plains NY, The Bronx NY, Belleville NJ,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07144280

Phase3, Recruiting

LUNG-ROLL: Treatment Patterns and Cost of Illness of Lung Cancer in Canada

for
Lung Neoplasms
Location: Toronto, Calgary
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT07143110

Recruiting